GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Piramal Pharma Ltd
Piramal Pharma Q4 FY26 results board meeting scheduled 28 April 2026
BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 17 Apr 2026, 02:17 PM IST  ·  BSE ID: f271f3a4-71e4-4822-9cc8-75f9ade341cf
View Original BSE Filing (PDF)
💡
In Simple Terms
Piramal Pharma will announce its full-year financial results on 28 April 2026; insider trading is restricted until then.
🤖 AI Summary
  • Board meeting scheduled 28 April 2026 to approve audited Q4 and FY26 results
  • Trading window closed 1 April through 30 April 2026 (inclusive)
  • Results presented in standalone and consolidated formats
  • Regulatory intimation under SEBI Regulation 29
👥 What This Means For Shareholders
✅
Action Required
No action required. Results will be publicly disclosed on scheduled date.
👤
Who Is Affected
All shareholders. Results announcement will affect all equity holders' understanding of company financial position and dividend eligibility assessment.
🔍
Management Signal
Routine results disclosure. Trading window closure confirms insider trading restrictions are in place ahead of material information release.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Results announcement 28 April 2026 — check revenue, profit, EPS, margin metrics
Trading window reopening 1 May 2026 — confirm insider trading restrictions lifted
Dividend announcement — check if board declares dividend from FY26 earnings
LOW RISK Routine regulatory disclosure. No material risks flagged. Results outcome will determine financial health assessment.
💡 Investor Takeaway
FY26 audited results (Q4 and full year) will be announced 28 April 2026. Trading window closed until 30 April. This is the first full-year reporting by the company — no prior year data available to assess growth.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.